Development and characterization of a first-in-class small molecule inhibitor of PELP1

被引：0
|
作者：
Altwegg, Kristin A. [1 ]
Viswanadhapalli, Suryavathi [1 ]
Mann, Monica [1 ]
Pratap, Uday P. [1 ]
Li, Mengxing [1 ]
Liu, Junhao [1 ]
Luo, Yiliao [1 ]
Sareddy, Gangadhara R. [1 ]
Vankayalapati, Hariprasad [2 ]
Vadlamudi, Ratna K. [1 ]
机构：
[1] UT Hlth San Antonio, San Antonio, TX USA
[2] Huntsman Canc Inst, Salt Lake City, UT USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-10-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-10-01
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER plus Breast Cancer
    Altwegg, Kristin A.
    Viswanadhapalli, Suryavathi
    Mann, Monica
    Chakravarty, Dimple
    Krishnan, Samaya
    Liu, Zexuan
    Liu, Junhao
    Pratap, Uday P.
    Ebrahimi, Behnam
    Sanchez, John R.
    Li, Xiaonan
    Ma, Shihong
    Park, Ben H.
    Santhamma, Bindu
    Chen, Yidong
    Lai, Zhao
    V. Raj, Ganesh
    Yuan, Yaxia
    Zhou, Daohong
    Sareddy, Gangadhara R.
    Tekmal, Rajeshwar R.
    McHardy, Stan
    Huang, Tim H. -M.
    Rao, Manjeet K.
    Vankayalapati, Hariprasad
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2022, 82 (20) : 3830 - 3844
  • [2] Development and preclinical assessment of a first-in-class small molecule inhibitor of FLIP
    Majkut, Joanna
    Higgins, Catherine
    Fox, Jennifer
    Fiedler, Greti E.
    Harrison, Timothy
    Longley, Daniel B.
    CANCER RESEARCH, 2017, 77
  • [3] Characterization of small molecule inhibitors of PELP1 for treating advanced breast cancer
    Altwegg, Kristin Ann
    Viswanadhapalli, Suryavathi
    Mann, Monica
    Pratap, Uday P.
    Li, Mengxing
    Liu, Junhao
    Luo, Yiliao
    Sareddy, Gangadhara R.
    Vankayalapati, Hariprasad
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Development and preclinical assessment of a first-in-class small-molecule inhibitor of FLIP
    Higgins, Catherine A.
    Majkut, Joanna
    Fox, Jennifer
    Humphreys, Luke
    Fiedler, Greti Espona
    Boffey, Ray J.
    Perrior, Trevor R.
    Haigh, David
    Harrison, Timothy
    Longley, Daniel B.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [5] Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
    Kristin A. Altwegg
    Uday P. Pratap
    Zexuan Liu
    Junhao Liu
    John R. Sanchez
    Xue Yang
    Behnam Ebrahimi
    Durga Meenakshi Panneerdoss
    Xiaonan Li
    Gangadhara R. Sareddy
    Suryavathi Viswanadhapalli
    Manjeet K. Rao
    Ratna K. Vadlamudi
    Breast Cancer Research and Treatment, 2023, 200 : 151 - 162
  • [6] Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
    Altwegg, Kristin A.
    Pratap, Uday P.
    Liu, Zexuan
    Liu, Junhao
    Sanchez, John R.
    Yang, Xue
    Ebrahimi, Behnam
    Panneerdoss, Durga Meenakshi
    Li, Xiaonan
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Rao, Manjeet K.
    Vadlamudi, Ratna K.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 200 (01) : 151 - 162
  • [7] Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP
    Higgins, Catherine A.
    Fox, Jennifer
    Majkut, Joanna
    Fiedler, Greti E.
    Roberts, Jamie
    Humphreys, Luke
    Boffey, Ray J.
    Perrior, Trevor R.
    Harrison, Timothy
    Longley, Daniel B.
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Small molecule inhibitor of PELP1 exhibit cytotoxic effects on breast cancer cells by blocking ribosome biogenesis
    Yang, Xue
    Nassar, Khaled Mohamed
    Pratap, Uday
    Gopalam, Rahul
    Ebrahimi, Behnam
    Panneerdoss, Durga Meenakshi
    Li, Xiaonan
    Yuan, Yaxia
    Zhou, Daohong
    Sareddy, Gangadhara R.
    Tekmal, Rajeshwar R.
    Rao, Manjeet
    Viswanadhapalli, Suryavathi
    Vadlamudi, Ratna
    CANCER RESEARCH, 2024, 84 (09)
  • [9] Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 Dimerization
    Bhatia, Sanil
    Spanier, Lukas
    Bickel, David
    Dienstbier, Niklas
    Woloschin, Vitalij
    Vogt, Melina
    Pols, Henrik
    Lungerich, Beate
    Reiners, Jens
    Aghaallaei, Narges
    Diedrich, Daniela
    Frieg, Benedikt
    Schliehe-Diecks, Julian
    Bopp, Bertan
    Lang, Franziska
    Gopalswamy, Mohanraj
    Loschwitz, Jennifer
    Bajohgli, Baubak
    Skokowa, Julia
    Borkhardt, Arndt
    Hauer, Julia
    Hansen, Finn K.
    Smits, Sander H. J.
    Jose, Joachim
    Gohlke, Holger
    Kurz, Thomas
    ACS CENTRAL SCIENCE, 2022, 8 (05) : 636 - 655
  • [10] Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP for treatment of NSCLC and CRC
    Higgins, C. A.
    Majkut, J.
    Humphreys, L.
    Fox, J.
    Espona-Fiedler, M.
    Malik, A.
    Nemeth, Z.
    Blurton, P.
    Boffey, R. J.
    Perrior, T. R.
    Haigh, D.
    Harrison, T.
    Longley, D. B.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S6 - S6
12345